Echo Systemic Sclerosis
NCT03143413 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-05-01
Summary
Systemic sclerosis is an autoimmune connective tissue disease with undefined etiology and characterized by progressive fibrosis of the skin and major organs. Dry eyes and / or buccal syndrome is commonly reported in patients with systemic sclerosis. Goujerot-Sjogren syndrome is a chronic autoimmune disorder that is characterized by dryness of the eyes (xerophthalmia) and / or mouth (xerostomia). It may be primary or secondary to another connective tissue disease (such as lupus, rheumatoid arthritis or other). Several criteria have been validated to classify the SS but require a labial salivary gland biopsy, invasive act which complications can sometimes be reported (hematoma, lip sensory defect).
Several scores based on the evaluation of the ultrasound homogeneity of the salivary glands were developed but no studies have evaluated ultrasound abnormalities of salivary glands in patients with systemic sclerosis.
Conditions
- Systemic Sclerosis
- Gougerot Sjogren Syndrome
- Sicca-Asthenia-Polyalgia Syndrome
Interventions
- OTHER
-
Ultrasonography
Patient will be enrolled in the rheumatology department of University hospital of Clermont-Ferrand (France). Salivary glands ultrasonography will be performed on all patients enrolled by the same expert and blinded to the diagnosis of the patient. Echostructure of the two salivary glands will be graded 0 to 4 and the size calculated.
Sponsors & Collaborators
-
University Hospital, Clermont-Ferrand
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-24
- Primary Completion
- 2019-03-31
- Completion
- 2019-05-31
Countries
- France
Study Locations
More Related Trials
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Hyperprolactinemia in Systemic Scleroderma
NCT04746313 ·Status: COMPLETED
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Primary Sjögren Syndrome
NCT01989819 ·Status: COMPLETED
-
Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
NCT01782235 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Interstitial Lung Diseases in Primary Sjogren's Syndrome
NCT04978883 ·Status: COMPLETED
-
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
NCT06847750 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Muscle Involvement in Systemic Sclerosis
NCT06051773 ·Status: RECRUITING
-
Assessment of Nutritional Status in Systemic Sclerosis
NCT04301596 ·Status: UNKNOWN
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
NCT04265144 ·Status: RECRUITING ·Phase: NA
-
Lower Urinary Tract Symptoms in Systemic Sclerosis
NCT01971294 ·Status: COMPLETED
-
Analysis of Cytokine Expression Pattern in Systemic Sclerosis
NCT03537105 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02422407 ·Status: COMPLETED
-
Implementation of a Biological Sample Collection in Systemic Sclerosis Patients
NCT04986514 ·Status: WITHDRAWN
-
Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
NCT03262922 ·Status: COMPLETED
-
AUTOANTIBODIES AND SYSTEMIC SCLEROSIS
NCT06502678 ·Status: NOT_YET_RECRUITING
-
Biomarkers in Primary Sjögren's Syndrome
NCT03765593 ·Status: UNKNOWN
-
What is the Optimal Follow-up for Patients With Systemic Sclerosis?
NCT05103553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc
NCT02795221 ·Status: UNKNOWN
-
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
NCT03816189 ·Status: COMPLETED
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED
-
Effect of Bosentan in Scleroderma Renal Crisis
NCT01241383 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
NCT03508375 ·Status: UNKNOWN ·Phase: NA